iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well-tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data.
Cristian GujaJános Tibor KisMartin HaluzíkMireille BonnemaireGregory BigotMathilde TournayNick FreemantleJochen SeufertPublished in: Diabetes, obesity & metabolism (2023)
iGlarLixi is effective and well-tolerated in both younger and older people with uncontrolled T2DM. This article is protected by copyright. All rights reserved.